GKOS Stock: Glaukos Corporation Stock Price, Analysis & Insights

Get live GKOS stock price $122.44, comprehensive Glaukos Corporation stock analysis, charts, news, and expert forecast. Real-time GKOS stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

122.44

3.09%Today

GKOS • Glaukos Corporation • New York Stock Exchange • Healthcare

Market Cap

7.19B

Volume

582.23K

52W High

148.11

52W Low

73.16

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, ...

Contact Information

Website: https://www.glaukos.com
Address: 229 Avenida Fabricante
Country: US

Investment Analysis & Business Insights

Healthcare

Medical - Devices

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Glaukos Corporation shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Glaukos Corporation
⚠Investors should consider how Glaukos Corporation fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

7.19B

P/E Ratio (TTM)

-36.99

Beta

0.81

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare GKOS with peer companies:

Arcellx, Inc. (ACLX)

Price: $115.07
Market cap: 6.73B

Alkermes plc (ALKS)

Price: $44.57
Market cap: 7.43B

Arrowhead Pharmaceuticals, Inc. (ARWR)

Price: $70.72
Market cap: 9.96B

Bausch + Lomb Corporation (BLCO)

Price: $15.46
Market cap: 5.51B

Bruker Corporation (BRKR)

Price: $55.62
Market cap: 8.47B

iRhythm Technologies, Inc. (IRTC)

Price: $115.43
Market cap: 3.79B

Merit Medical Systems, Inc. (MMSI)

Price: $67.68
Market cap: 4.04B

Oscar Health, Inc. (OSCR)

Price: $27.98
Market cap: 7.25B

Teleflex Incorporated (TFX)

Price: $135.44
Market cap: 6.00B

TransMedics Group, Inc. (TMDX)

Price: $76.75
Market cap: 2.65B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.